| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.98B | 45.36B | 42.91B | 39.80B | 34.77B | 32.24B |
| Gross Profit | 9.02B | 9.80B | 9.28B | 8.52B | 7.28B | 7.14B |
| EBITDA | 4.18B | 4.79B | 4.21B | 3.86B | 2.80B | 3.03B |
| Net Income | 2.46B | 2.94B | 2.59B | 2.37B | 1.65B | 1.69B |
Balance Sheet | ||||||
| Total Assets | 39.77B | 41.63B | 40.35B | 36.88B | 33.65B | 30.59B |
| Cash, Cash Equivalents and Short-Term Investments | 11.50B | 14.60B | 12.62B | 10.18B | 10.36B | 9.30B |
| Total Debt | 1.12B | 85.00M | 104.00M | 125.00M | 150.00M | 188.00M |
| Total Liabilities | 15.67B | 14.53B | 15.38B | 13.89B | 12.52B | 10.61B |
| Stockholders Equity | 24.10B | 27.10B | 24.96B | 22.99B | 21.12B | 19.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.11B | 3.52B | 501.00M | 1.65B | 1.28B |
| Operating Cash Flow | 0.00 | 3.56B | 4.11B | 817.00M | 1.90B | 1.56B |
| Investing Cash Flow | 0.00 | -788.00M | -934.00M | -471.00M | -304.00M | -306.00M |
| Financing Cash Flow | 0.00 | -785.00M | -732.00M | -527.00M | -539.00M | -424.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥46.91B | 14.35 | ― | 3.74% | 3.70% | 12.26% | |
75 Outperform | ¥143.86B | 9.90 | ― | 1.92% | 12.72% | 28.48% | |
74 Outperform | ¥26.25B | 11.95 | ― | 7.56% | 8.01% | 13.19% | |
69 Neutral | ¥87.55B | 13.57 | ― | 3.65% | 8.96% | -0.82% | |
66 Neutral | ¥129.65B | 10.42 | 12.89% | 3.40% | 2.98% | 41.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥5.85B | 4.98 | ― | 4.13% | 2.76% | -10.23% |